The apolipoprotein(a) 
Introduction
Apolipoprotein(a) [apo(a)] is a high-molecular-weight glycoprotein, which is connected to apolipoprotein B-100 in lipoprotein(a) (Lp[a]) 1 (1) (2) (3) (4) . Apo(a) shares homologous domains with plasminogen, including a signal peptide, variable repetitive domains of plasminogen kringle 4 (K4), a single plasminogen kringle 5, and a (pseudo)serine protease domain (5) . Lp(a) acts as an anti-fibrinolytic factor in that it competes with plasminogen in the fibrin-binding (6) (7) (8) , resulting in the inhibition of clot lysis (7, 9) . Concentrations of Lp(a) in plasma vary among individuals from 0 to more than 200 mg/dl over a range of 1,000-fold (2, 3) . A population with a plasma Lp(a) level higher than 25-30 mg/dl has a higher incidence of acute myocardial infarction and cerebral infarction (2-4, 10, 11) .
The apo(a) locus contributes to greater than 90% of the variation in plasma Lp(a) concentrations and the number of K4 repeats in the apo(a) gene accounts for ‫ف‬ 70% of the variation (12, 13) . Although the plasma Lp(a) concentration roughly correlates with the size and number of K4 repeats of apo(a) (14, 15), a significant variation in the Lp(a) level exists among individuals having the same isoform (16, 17) . Several lines of evidence indicate that the plasma concentration of Lp(a) is determined by the rate of its synthesis, and not by the rate of catabolism (18) (19) (20) ; the catabolic rates of Lp(a) isoforms are not different regardless of the apo(a) size. Thus the genetic variation of the Lp(a) production rate in each apo(a) isoform may be caused by a difference in the apo(a) gene transcription, protein translation, or its secretion, etc. In a cynomolgus monkey model, plasma Lp(a) levels correlated with hepatic mRNA abundance (21).
In our previous studies (22, 23) , nucleotide sequence analysis of the apo(a) gene revealed the presence of polymorphisms in its 5 Ј -flanking region: G/A at the positions Ϫ 773, C/T at ϩ 93, and G/A at ϩ 121, relative to the transcription start site (24) . Since the nucleotide substitutions can be distinguished by the presence or absence of restriction sites for TaqI, MaeII, and HhaI endonucleases, respectively, the apo(a) alleles among individuals are classified by restriction digestion analysis into four types (23) .
The differences in the nucleotide sequence of the 5 Ј -regulatory region may lead to differential transcriptional and/or translational efficiency, which in turn result in a wide variety of plasma Lp(a) levels, not only among individuals but also between ethnic groups (2, 25) . In the present study, this hypothesis was tested in vivo by measuring plasma Lp(a) levels and in vitro by the chloramphenicol acetyltransferase (CAT) assay, when each of the four types of 5 Ј -alleles was inserted into a promoterless CAT vector and their expression efficiency was compared directly.
Methods
Venous blood was drawn after informed consent had been obtained from normal individuals, patients with cerebral infarction, and their family members. A Tint Elize Lp(a) immunoassay kit was purchased from Biopool AB (Sweden). Genomic DNA samples were extracted from the leukocytes. HepG2, a human hepatocarcinoma cell line, was obtained from the Japanese Cancer Research Resources Bank (Tokyo). Reporter vectors, pCAT-Basic, -Enhancer, -Control, and pSV-␤ -Galactosidase Control were purchased from Promega (Madison, WI).
ELISA for plasma Lp(a) levels. Plasma Lp(a) concentrations were measured by an ELISA kit following the manufacturer's instructions. 96-well ELISA plates (Corning, NY) were first coated with an antiapo(a) monoclonal antibody at 4 Њ C overnight before plasma samples were incubated. The wells were then incubated with an anti-apo(a) polyclonal antibody, peroxidase-conjugated rabbit anti-mouse immunoglobulin, and a substrate solution. Standard Lp(a) supplied by the manufacturer was used to estimate its concentrations in test samples.
Determination of apo(a) size. Apo(a) isoform size was determined by agarose/SDS-PAGE of plasma and subsequent Western blotting as described by Perombelon et al. (17) . Delipidated and lyophilized samples from 8-100 l of plasma were dissolved in 100 l of sample buffer (45 mM Tris-HCl pH 6.8, containing 5% SDS, 10% Glycerol, 0.015% bromophenol blue, 10% ␤ -mercaptoethanol) at 100 Њ C for 4 min. The samples were run through 3% polyacrylamide gel containing 0.5% agarose. Proteins were transferred to nitrocellurose membranes and the bands of apo(a) were detected by employing a mouse anti-human Lp(a) antibody (Terumo, Tokyo, Japan). Apparent molecular weights of isoforms were estimated by Ferguson plots employing crosslinked phosphorylase b as high molecular weight markers (Sigma Chemical Co., St. Louis, MO). Statistical analysis was performed using the StatView program (Abacus Concepts, Inc., Berkeley, CA).
Construction of CAT vectors. The promoter region of the apo(a) gene, a 1164-bp fragment extending from positions Ϫ 1017 to ϩ 147 relative to the start site of transcription (24, 26) , was prepared by PCR (polymerase chain reaction) using human genomic DNA as a template. Oligonucleotide primers were designed from the genomic sequence of apo(a) (22, 27) , and flanked either by a synthetic PstI or XbaI restriction site at the 5 Ј ends: pair 1 (for amplification of types A, B, and D), 5 Ј -side, 5 Ј -CCTCCTGCAGTGCTGGGATTACA-GAGTTGA-3 Ј and 3 Ј -side, 5 Ј -ATGTCTAGATTTGGGACTGGC-CAGCAGTGC-3 Ј ; pair 2 (for amplification of type C), 5 Ј -side, 5 Ј -CCTCCTGCAGTGCTGGGATTACAGAGTTGA-3 Ј and 3 Ј -side, 5 Ј -ATGTCTAGATTTGGGACTGGCCAGCAGTGT-3 Ј (PstI and XbaI sites underlined). PCR was carried out in a 50 l reaction mixture as described (28) using 2.5 units of Thermus aquaticus DNA polymerase (Taq polymerase; StrataGene, La Jolla, CA). Genomic DNAs were subjected to 30 cycles of amplification by heating at 94 Њ C for 1 min to denature the DNA, cooling to 68 Њ C for 1 min to anneal primers, and incubating at 72 Њ C for 1 min to extend the annealed primers. The PCR products were then digested with PstI and XbaI endonucleases, and ligated into a promoterless pCAT-Enhancer vector between unique PstI and XbaI sites. The constructed plasmids were designated as pCAT-A, B, C, and D ( Fig. 1 A, top four ), corresponding to each of the four 5 Ј -alleles (23) .
A 5 Ј -deletion mutant of each subtype containing a genomic fragment of apo(a) extending from Ϫ 304 to ϩ 147 was constructed from either pCAT-A, B, C, or D by digestion with HindIII endonuclease (to cleave the HindIII site within the insert) and with XbaI endonuclease (to cleave the XbaI site in the vector). The DNA fragments were subcloned into a HindIII/XbaI-digested pCAT-Enhancer vector. The constructed plasmids containing two polymorphic sites at positions ϩ 93 and ϩ 121 were designated as pCAT-∆ A, ∆ C, and ∆ D (Fig. 1 A, middle three ; pCAT-∆ A and pCAT-∆ B are identical). In addition, 3 Ј -deletion mutants containing genomic fragments extending from Ϫ 304 to ϩ 120 were constructed from pCAT-∆ A, ∆ C, and ∆ D by digestion with Bsp1286I endonuclease (to cut the site within the insert at position ϩ 120). The DNA fragments were then isolated from agarose gels, blunted by T4 DNA polymerase (Takara, Otsu, Japan), and digested with HindIII endonuclease. The resulting HindIII/ blunt-end fragments of the apo(a) gene were cloned into the HindIII/ XbaI-digested pCAT-Enhancer vector in which the XbaI cohesive terminus was changed to a blunt end by T4 DNA polymerase. These constructed plasmids contained only one polymorphic site at position ϩ 93 and were designated as pCAT-3 Ј⌬ A and 3 Ј⌬ D ( Fig. 1 A, bottom two ; pCAT-3 Ј⌬ A and pCAT-3 Ј⌬ C are identical). The sequence of the inserts in all vectors was confirmed by the dideoxy chain termination method (29) using a Sequenase kit (United States Biochemical, Cleveland, OH) and oligonucleotide primers prepared in the previous studies (22, 27) .
Cell culture and transient transfection. HepG2 cells were grown in 100-mm dishes in Dulbecco's modified Eagle's medium (DME; Nikken Biomedical Laboratory, Kyoto, Japan) containing 10% fetal bovine These fragments were inserted into a promoterless pCATEnhancer vector. 5Ј-deletion mutants (⌬A, ⌬C, and ⌬D; middle three) were constructed from each subtype of the pCAT plasmids. 3Ј deletion mutants (3Ј⌬A and 3Ј⌬D, bottom two) were also constructed from the 5Ј deletion mutants. (B) Expression activity of four 5Ј-alleles of the apo(a) gene and their deletion mutants. HepG2 cells were transfected with test plasmids together with a pSV-␤-Galactosidase vector as a control for transfection efficiency. CAT activity was normalized to ␤-galactosidase activity and was presented relative to that of type A (100%). serum (SEBAK GmbH, Germany), 50 g/ml penicillin, 50 g/ml streptomycin, and 100 g/ml neomycin (PSN Antibiotic Mixture; GIBCO BRL, Gaithersburg, MD). For transient transfection, plasmids were prepared by double ultracentrifugation using cesium chloride density gradient. 2-3 ϫ 10 6 HepG2 cells were transfected by the calcium phosphate method (30) with 10 g of test plasmids carrying a reporter gene and 5 g of pSV-␤ -Galactosidase plasmid to monitor the efficiency of transfection. Both pCAT-Basic and -Control vectors were also used as negative and positive controls, respectively, for the expression experiments. The cells were incubated for 5 h and shocked with 15% (vol/vol) glycerol in Hepes-buffer saline for 2 min. After being cultured for 48 h, the cells were harvested for analysis of chloramphenicol acetyltransferase (CAT) and ␤ -galactosidase expression.
These experiments were also carried out using a human cervical carcinoma (cell line), HeLa cells, and baby hamster kidney (BHK) cells.
CAT and ␤ -galactosidase assays. To evaluate the expression of reporter plasmids, cells were removed from culture plates with 0.25% trypsin and 1 mM EDTA, washed with phosphate buffered saline (PBS) twice, and resuspended in 200 l of 0.25 M Tris-HCl, pH 7.8. The cells were then lysed by three freeze/thaw cycles and centrifuged, and 50 l of supernatant was then examined for CAT activity by a standard method (31). To evaluate the expression of the pSV-␤ -Galactosidase Control vector, 30 l of the supernatant of cell lysates was mixed with 201 l of 0.1 M sodium phosphate buffer (pH 7.8), 66 l of o -nitrophenyl ␤ -d -galactopyranoside (ONPG; Sigma Chemical Co.), and 3 l of 0.1 M MgCl 2, 4.5 M ␤ -mercaptoethanol. Samples were incubated at 37 Њ C for 30 min and reaction was then stopped with 500 l of Na 2 CO 3 . ␤-galactosidase activity was measured by absorption at 420 nm (32) . CAT activities were normalized to ␤-galactosidase activity for each dish. Within each experiment CAT activity was determined in duplicate or triplicate dishes, and each plasmid was tested in three to five separate experiments; therefore results are expressed as the mean of 6-10 values.
Results
Relationship between 5Ј-alleles and plasma Lp(a) levels. To investigate whether or not the 5Ј-alleles of the apo(a) gene affect plasma Lp(a) levels, we measured plasma Lp(a) levels by ELISA in patients with cerebral infarction and their family members (n ϭ 55, Fig. 2) . Their 5Ј-alleles were determined in the previous study (23) . Plasma Lp(a) levels were significantly higher (P ϭ 0.036) in homozygotes (n ϭ 13) of the type C allele than in those (n ϭ 8) of the type D allele (meansϮSD; 35.8Ϯ22.8 vs. 17.5Ϯ16.2 mg/dl). The difference in Lp(a) levels between these two groups cannot be attributed to the size polymorphism in apo(a), due to the differences in the number of K4 repeats, since the averages of the molecular weights were essentially the same for both groups (CC 906Ϯ291 vs. DD 895Ϯ91 kD, P ϭ 0.911). Plasma Lp(a) concentrations varied and weakly correlated inversely with apo(a) size within the same 5Ј-allele (CC r ϭ Ϫ0.64, DD r ϭ Ϫ0.50) as well as in the total for all groups (r ϭ Ϫ0.57) as shown in Fig. 3 . Although differences in the averages of Lp(a) levels between other allelic groups were not significant, it was noteworthy that the average of heterozygotes of types C and D (n ϭ 18, 27.8Ϯ23.4 mg/dl) was between that of homozygotes of type C and that of type D. Accordingly, it is very likely that the wide variation within the same apo(a) isoform (size) is caused at least in part by the difference in the 5Ј-alleles. We therefore compared the promoter activity of the four types of 5Ј-allele, including types C and D, to test whether the difference in Lp(a) levels was attributable to the difference in apo(a) expression and in nucleotide sequence.
Expression efficiency of four 5Ј-alleles. To compare promoter activity of the four 5Ј-alleles in vitro, a CAT reporter gene assay was used. Each DNA fragment (1.2-kb) carrying one of four 5Ј-alleles was prepared by PCR and inserted into the pCAT-Enhancer vector upstream of the CAT gene (Fig.  1 A, top) . A test plasmid and ␤-Galactosidase Control plasmid were co-transfected into HepG2 cells, and examined for CAT and ␤-galactosidase expression. The HepG2 cells, in which the apo(a) mRNA was detected (5), have been exclusively used for the CAT assay of the apo(a) gene (24, 26, 33, 34) . CAT activity was normalized to ␤-galactosidase activity and was presented as a percentage of the type A allele (100%). The relative promoter activity was 103Ϯ22.6% for type B, 191Ϯ39.5% for type C, and 67Ϯ10.9% for type D (Fig. 1 B, top) . Thus, the relative expression efficiency of type C was about three times higher than that of type D. These experiments were also carried out using HeLa cells, a human cervical carcinoma cell line, as well as baby hamster kidney (BHK) cells, but, in these cells, no CAT activity for the apo(a) gene was detected (data not shown). These results indicated that the apo(a) gene is specifically expressed in hepatic cells, which is consistent with the fact that its mRNA is most abundant in the liver (5, 21) .
Effect of each polymorphic site on expression. To explore the effects of the three polymorphic sites on the regulation of apo(a) expression, we performed deletion analysis for each pCAT plasmid containing 5Ј-alleles. Three 5Ј-deletion mutants carrying 451-bp genomic fragments from Ϫ304 to ϩ147 contained two polymorphic sites at ϩ93 and ϩ121 (Fig. 1 A, middle) . Type ⌬A and type ⌬B were judged to be identical because the 5Ј-portion (from Ϫ1017 to Ϫ305 including a polymorphism at Ϫ773) was absent in these deletion mutants. The CAT activity of type ∆A was 150 Ϯ5.9%, type ∆C was 181Ϯ12.4%, and type ∆D was 91Ϯ9.0% that of type A (Fig. 1 B, middle) .
Two 3Ј-deletion mutants (3Ј⌬A and 3Ј⌬D), each carrying a genomic fragment of 424-bp from Ϫ304 to ϩ120, contained only one polymorphic site at ϩ93 (Fig. 1 A, bottom) . The CAT activity of type 3Ј⌬A was 3.8Ϯ0.30%, and type 3Ј⌬D was 2.1Ϯ0.47% that of the type A (675Ϯ53 vs. 242Ϯ54 cpm, Fig.  1 B) . Thus, one nucleotide substitution at ϩ93 led to the difference in promoter activity, despite the fact that the deletion from ϩ121 to ϩ147 caused a great reduction in the activity of both mutants.
Discussion
Since plasma concentrations of Lp(a) vary widely among individuals, even among those having the same apo(a) isoform (16, 17) , there must be a difference in the nucleotide sequence linked to the apo(a) locus other than the number of K4 repeats. We recently reported the presence of polymorphisms in the 5Ј-flanking region of the apo(a) gene (22) . Additionally, genomic DNAs from normal individuals have been subclassified into four 5Ј-alleles by genetic diagnosis (23) .
In this study, to explore the mechanisms of genetic control of plasma Lp(a) levels, we measured plasma Lp(a) concentrations in vivo by ELISA and examined the expression of its gene by an in vitro CAT assay. It was found that there was a clear relationship between 5Ј-alleles and plasma Lp(a) levels.
Lp(a) levels in homozygotes of the type C allele were significantly higher (about two times) than in homozygotes of the type D allele, suggesting that at least some 5Ј-alleles are associated with different levels of plasma Lp(a).
The CAT assay revealed that the promoter activity of type C was higher than that of type D, indicating that these in vitro results are consistent with the in vivo results as described above, and that the 5Ј-alleles have differences not only in their nucleotide sequences, but also in their promoter activity. Thus, other than the number of K4 repeats, the sequence variation at the apo(a) locus is associated with the genetic control of apo(a) expression and with Lp(a) concentrations.
Recently, another research group reported similar findings with regard to types A (ϩ93C in reference 33) and D (ϩ93T in reference 33); however, their results are somewhat confusing in that they stated that type A (A1 in reference 24) was fivefold more active than type B (A2 in reference 24). Moreover, their study does not include deletion analysis of the polymorphic sites. It has also been reported by others that a difference in the number of tandem repeats ([TTTTA]n) located 1.3 kb upstream of the transcription initiation site of the apo(a) gene is not related to the transcriptional activity (34) .
To define the effect of each polymorphism on apo(a) expression, 5Ј-deletion analysis of the four 5Ј-alleles was carried out (Fig. 1 B) . There is a difference of only a single nucleotide at position ϩ121 (HhaI site) between types ∆A and ∆C. The relative CAT activity of type ⌬C (HhaIϪ) was about 1.2-fold that of type ⌬A (HhaIϩ) and that of type C was twofold that of type A, while the activities of type C and type ⌬C were essentially the same. Thus, the difference in CAT activity between type A and type C may depend on the differential interaction between the HhaI site and a further upstream region(s). It is possible that the TaqI site at position Ϫ773 affects the function of the HhaI site in expression; the removed region between Ϫ1017 and Ϫ304, including the TaqI site, may have a significant silencer function only in combination with the presence of the HhaI site at position ϩ121. However, it seems likely that the polymorphism at Ϫ773 would have a small effect, if any, since there is no significant difference in the CAT activity between types A and B, which differ only in the single nucleotide at Ϫ773.
Both 5Ј-deletion mutants ∆A and ∆D demonstrated higher CAT activity ‫ف(‬ 1.5-fold) than did their parent types, indicating that the removed fragment contains negative regulatory elements (silencers). Type ⌬A and type ⌬D differ in only one nucleotide at position ϩ93 (the MaeII site). The relative CAT activity of type ⌬D (MaeII Ϫ) was about two-thirds that of type ⌬A (MaeII ϩ), which reflects the ratio of the activity of their respective parent types exactly. Therefore, the differential CAT activity would appear to depend at least in part on the MaeII site.
This conclusion was also confirmed by the results of 3Ј-deletion analysis, since CAT activity of type 3Ј⌬A (MaeII ϩ) was about twofold that of 3Ј⌬D (MaeIIϪ). There was a marked reduction in the activity of both mutants. The removed fragment may have an essential sequence(s) for transcription as reported by Wade et al. (26) . These results suggest that both polymorphisms (positions ϩ93 and ϩ121) affect the promoter activity of the four 5Ј-alleles. MaeII (Ϫ) allele (ϩ93T) has lower activity when compared with MaeII (ϩ) allele (ϩ93C), while HhaI (Ϫ) allele (ϩ121A) exhibits higher activity when compared with HhaI (ϩ) allele (ϩ121G) (Fig. 4) .
In the 5Ј-flanking region of the apo(a) gene, several major protein-binding sites were identified by DNase protection assays (26) . The polymorphism at ϩ93 is included within a protein-binding site containing an AP-1 site, and the polymorphism at ϩ121 is located near a protein-binding site including a CEBP site and an IL-6-responsive element (Fig. 4) . Both sites have been confirmed by site-directed mutagenesis to have significant effects on expression of the apo(a) gene (26) . Therefore, the differential promoter activity of the four 5Ј-alleles may be caused by a gain and/or loss of binding sites for transcription factors as a result of these nucleotide substitutions. However, it was proposed that the polymorphism at position ϩ93 reduced the efficiency of translation rather than transcription (33) . This type of gene regulation was reported in several genes including that for the androgen receptor (35) .
Thus, we have concluded in this study that the nucleotide polymorphism in the 5Ј-flanking region of the apo(a) gene (5Ј-allele) is one of the major factors which determine plasma Lp(a) levels. The apo(a) gene is highly polymorphic both in size and in sequence, which in turn leads to the wide variety of plasma Lp(a) levels seen among individuals. We recently reported that the ratio of the 5Ј-alleles of apo(a) differed between normal individuals and patients with myocardial infarction (23) in which elevated Lp(a) levels were found (36) (37) (38) . The high Lp(a) levels observed in myocardial infarction can be explained in part by the fact that there are less individuals having type D, which has low expression efficiency of the apo (a) gene. To elucidate the clinical significance of these nucleotide polymorphisms in the pathological roles of apo(a), further studies are required, e.g., determination of the relationships between the 5Ј-alleles, plasma concentrations of Lp(a), and the incidence of atherothrombotic disease.
As reported by other investigators (16, 17) , the weak inverse correlation between plasma Lp(a) concentrations and apo(a) size was also observed in our study. However, Lp(a) levels varied even within the same 5Ј-allele having similar apo(a) isoforms (Fig. 3) , suggesting that the apo(a) expression is also affected by non-genetic factors, e.g. cytokines and hormones, since Lp(a) levels change under various conditions (39, 40) . Alternatively, other genetic elements other than the 5Ј-allele and the number of K4 repeats may play a role in the regulation of the apo(a) expression, although such elements are not known to date. 
